Nowadays in the research and development of new drugs involves more than 130 employees of BIOCAD, of which 20 have advanced scientific degrees. The company has all the units that are required for the development of original and generic drugs, from molecular biology laboratory to the department of pre-clinical studies. Development of new medicines is performed according to GLP.
BIOCAD is a leader among Russian companies in the number of clinical trials conducted. The medical department employs doctors - experts in the field of oncology, neurology, and infectious diseases, dealing with planning of clinical studies and the analysis of results, as well as experts in organizing clinical trials and monitoring studies in accordance with the GCP standards .
Development of biotechnological products: from genetic engineering to preclinical testing.